Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is W  [Clear All Filters]
2013
Gertow K, Hirst CE, Yu QC, Ng ES, Pereira LA, Davis RP, Stanley EG, Elefanty AG. WNT3A Promotes Hematopoietic or Mesenchymal Differentiation from hESCs Depending on the Time of Exposure. Stem Cell Reports. 2013;1(1):53-65.
Leucht P, Jiang J, Cheng D, Liu B, Dhamdhere G, Fang MYang, Monica SD, Urena JJ, Cole W, Smith LR, et al. Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals. J Bone Joint Surg Am. 2013;95(14):1278-88.
Cook DA, Fellgett SW, Pownall ME, O'Shea PJ, Genever PG. Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitor. Stem Cell Res. 2013;12(2):415-427.
Cai W-Y, Wei T-Z, Luo Q-C, Wu Q-W, Liu Q-F, Yang M, Ye G-D, Wu J-F, Chen Y-Y, Bin Sun G-, et al. Wnt/β-catenin pathway represses let-7 microRNAs expression via transactivation of Lin28 to augment breast cancer stem cell expansion. J Cell Sci. 2013.
Gu Z, Tan W, Feng G, Meng Y, Shen B, Liu H, Cheng C. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway. Mol Cell Biochem. 2013.
Zhang B, Krawetz R, Rancourt DE. Would the real human embryonic stem cell please stand up?. Bioessays. 2013.
Gish LA, Gagne JM, Han L, Deyoung BJ, Clark SE. WUSCHEL-Responsive At5g65480 Interacts with CLAVATA Components In Vitro and in Transient Expression. PLoS One. 2013;8(6):e66345.

Pages